Centene Corporation (CNC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with revenue, net income, and EPS all showing significant year-over-year growth. The company also achieved an improved Medical Loss Ratio and operating cash flow. While forward-looking statements carry inherent risks, the absence of negative sentiment in the Q&A and the optimistic financial metrics suggest a positive outlook. Despite the lack of operational updates, strategic initiatives, and return discussions, the strong financial results and efficient cost management support a positive stock price movement prediction.
Key Financial Performance
Revenue Centene reported a revenue of $38.9 billion for Q1 2026, which represents a 7% increase year-over-year. The growth was driven by higher membership in Medicaid and Medicare programs, as well as premium rate increases.
Net Income Net income for Q1 2026 was $1.2 billion, up 15% year-over-year. This increase was attributed to improved operating efficiencies and cost management initiatives.
Earnings Per Share (EPS) The EPS for Q1 2026 was $2.10, reflecting a 16% increase compared to the same period last year. The rise was due to higher net income and share repurchase activities.
Medical Loss Ratio (MLR) The MLR for Q1 2026 was 87.2%, an improvement of 0.5 percentage points year-over-year. This was due to better management of medical costs and favorable claims experience.
Operating Cash Flow Operating cash flow for Q1 2026 was $2.5 billion, which is a 20% increase year-over-year. The improvement was driven by higher earnings and efficient working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: The company's commentary on its full year 2026 outlook, including the drivers of such outlook, are forward-looking statements. Actual results may differ materially from those indicated by those forward-looking statements as a result of various factors.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Bernstein Institutional
CFO Mok
Centene Instructions
Centene expectation
Co Research
Director Asher
Division Albert
Division EDT
Division Erin
Division George
Division Justin
Division Kevin
Division Scott
Division Windley
EDT day
Erin Wilson
Executive VP
Fidel Goldman
George Hill
Kevin Fischbeck
LLC Ann
LLC Research
President Investor
Relations remark
Research Division
Scott Fidel
Senior Vice
Stanley Research
VP CFO
Wilson Wright
commentary outlook
day Centene
driver outlook
outlook driver
outlook statement
remark Centene
CNC Transcript
Centene Corporation (CNC) Q1 2026 Earnings Call Transcript
Positive4-28
The earnings call reveals strong financial performance with revenue, net income, and EPS all showing significant year-over-year growth. The company also achieved an improved Medical Loss Ratio and operating cash flow. While forward-looking statements carry inherent risks, the absence of negative sentiment in the Q&A and the optimistic financial metrics suggest a positive outlook. Despite the lack of operational updates, strategic initiatives, and return discussions, the strong financial results and efficient cost management support a positive stock price movement prediction.
Centene Corporation (CNC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Centene Corporation (CNC) Q4 2025 Earnings Call Transcript
Unknown2-6
The earnings call reveals a mixed sentiment. Positive aspects include increased EPS forecast, margin improvements, and operational focus. However, concerns arise from potential investment losses, higher tax rates, and lack of breakeven in Medicare Advantage by 2026. The Q&A section highlights cautious optimism with some uncertainties, such as Medicaid trends and management's vague responses. Overall, the sentiment is balanced, resulting in a neutral outlook.
Centene Corporation (CNC) Presents at UBS Global Healthcare Conference 2025 Transcript
Neutral11-11
CNC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
